CRISPR/Cas9 technology introduced a 3 bp CCC to TTG change in exon 12 resulting in a proline to leucine substitution at position 479 (P479L). (J:284256)
查看原文 参与反馈
CRISPR/Cas9 technology introduced a 3 bp CCC to TTG change in exon 12 resulting in a proline to leucine substitution at position 479 (P479L). (J:284256)